Clinical Trial

Targeting Real World Usage In Stroke Treatment

Study acronym: TRUST
Recruiting
View on ClinicalTrials.gov →
Summary
TRUST Registry is an observational, prospective, long-term, post-market surveillance registry of subjects treated with WallabyPhenox flow modulation devices, stent systems, bifurcation aneurysm implants including their HPC variants (Hydrophilic Polymer Coating) where applicable as well as coil systems, and other adjunctive medical devices. The overarching purpose of this registry is to carry out a proactive gathering, recording, and analysis of data on the safety, performance and usability of the devices as applied within the routine practice of the participating registry sites.
Trial Details
NCT Number NCT07474935
Lead Sponsor Phenox GmbH
Conditions Saccular and Fusiform Aneurysms, Pseudoaneurysm, Vascular Dissection, Perforation, Bifurcation Aneurysms, Stenosis, Neurovascular Abnormalties, Wide-neck Aneurysm +1 more
Enrollment 5,000 participants
Start Date 2026-01-29
Primary Completion 2036-01 (estimated)
Study Completion 2041-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-16